Breakthrough Drug for Chronic Lymphocytic Leukemia
1 Views
administrator
07/08/23
A breakthrough drug called ACP-196 is showing remarkable potential for effectively treating chronic lymphocytic leukemia, or CLL. Researcher Dr. Amy Johnson explains how a daily pill might completely change the way CLL is treated. Still being studied, ACP-196 has delivered excellent results to date, with 95% of patients experiencing favorable results – and with very few side effects – meaning it might be the answer to offering extraordinary outcomes for CLL patients.
-
Category
Show more
Facebook Comments
No comments found